An incomplete correlogram was originally supplied for Figure 7. A revised version of the figure has been provided, and no changes to the text were necessary. The revision does not affect the findings and conclusions presented in the article.
. 2025 Dec 16;67(1):100947. doi: 10.1016/j.jlr.2025.100947
Correction for: ApoB100 remodeling and stiffened cholesteryl ester core raise LDL aggregation in familial hypercholesterolemia patients [Journal of Lipid Research 66/1 (2025) 100703]
Maria Teresa La Chica Lhoëst
1,2,3,4, Andrea Martínez
1,2,3, Eduardo Garcia
1,2,3,4, Jany Dandurand
5, Anna Polishchuk
1,2,3, Aleyda Benitez-Amaro
1,2,3, Ana Cenarro
6,7, Fernando Civeira
6,7, Amable Bernabé
8, David Vilades
7,9, Joan Carles Escolà-Gil
3,4,10, Valerie Samouillan
5, Vicenta Llorente-Cortes
1,2,3,7,∗
Maria Teresa La Chica Lhoëst
1Experimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB)-Spanish National Research Council (CSIC), Barcelona, Spain
2Cardiovascular Area, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain
3Cardiovascular Area, Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques IIB Sant Pau, Barcelona, Spain
4Biochemistry Department, Universitat Autònoma de Barcelona, Barcelona, Spain
Find articles by Maria Teresa La Chica Lhoëst
Andrea Martínez
1Experimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB)-Spanish National Research Council (CSIC), Barcelona, Spain
2Cardiovascular Area, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain
3Cardiovascular Area, Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques IIB Sant Pau, Barcelona, Spain
Find articles by Andrea Martínez
Eduardo Garcia
1Experimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB)-Spanish National Research Council (CSIC), Barcelona, Spain
2Cardiovascular Area, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain
3Cardiovascular Area, Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques IIB Sant Pau, Barcelona, Spain
4Biochemistry Department, Universitat Autònoma de Barcelona, Barcelona, Spain
Find articles by Eduardo Garcia
Jany Dandurand
5CIRIMAT, Université de Toulouse Paul Sabatier, Equipe PHYPOL, Toulouse, France
Find articles by Jany Dandurand
Anna Polishchuk
1Experimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB)-Spanish National Research Council (CSIC), Barcelona, Spain
2Cardiovascular Area, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain
3Cardiovascular Area, Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques IIB Sant Pau, Barcelona, Spain
Find articles by Anna Polishchuk
Aleyda Benitez-Amaro
1Experimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB)-Spanish National Research Council (CSIC), Barcelona, Spain
2Cardiovascular Area, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain
3Cardiovascular Area, Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques IIB Sant Pau, Barcelona, Spain
Find articles by Aleyda Benitez-Amaro
Ana Cenarro
6Hospital Universitario Miguel Servet, IIS Aragón, Instituto Aragonés de Ciencias de la Salud, Universidad de Zaragoza, Zaragoza, Spain
7CIBER de Enfermedades Cardiovasculares CIBERCV, Institute of Health Carlos III, Madrid, Spain
Find articles by Ana Cenarro
Fernando Civeira
6Hospital Universitario Miguel Servet, IIS Aragón, Instituto Aragonés de Ciencias de la Salud, Universidad de Zaragoza, Zaragoza, Spain
7CIBER de Enfermedades Cardiovasculares CIBERCV, Institute of Health Carlos III, Madrid, Spain
Find articles by Fernando Civeira
Amable Bernabé
8Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra, Spain
Find articles by Amable Bernabé
David Vilades
7CIBER de Enfermedades Cardiovasculares CIBERCV, Institute of Health Carlos III, Madrid, Spain
9Cardiac Imaging Unit, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain
Find articles by David Vilades
Joan Carles Escolà-Gil
3Cardiovascular Area, Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques IIB Sant Pau, Barcelona, Spain
4Biochemistry Department, Universitat Autònoma de Barcelona, Barcelona, Spain
10CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain
Find articles by Joan Carles Escolà-Gil
Valerie Samouillan
5CIRIMAT, Université de Toulouse Paul Sabatier, Equipe PHYPOL, Toulouse, France
Find articles by Valerie Samouillan
Vicenta Llorente-Cortes
1Experimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB)-Spanish National Research Council (CSIC), Barcelona, Spain
2Cardiovascular Area, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain
3Cardiovascular Area, Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques IIB Sant Pau, Barcelona, Spain
7CIBER de Enfermedades Cardiovasculares CIBERCV, Institute of Health Carlos III, Madrid, Spain
Find articles by Vicenta Llorente-Cortes
1Experimental Pathology Department, Institute of Biomedical Research of Barcelona (IIBB)-Spanish National Research Council (CSIC), Barcelona, Spain
2Cardiovascular Area, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain
3Cardiovascular Area, Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques IIB Sant Pau, Barcelona, Spain
4Biochemistry Department, Universitat Autònoma de Barcelona, Barcelona, Spain
5CIRIMAT, Université de Toulouse Paul Sabatier, Equipe PHYPOL, Toulouse, France
6Hospital Universitario Miguel Servet, IIS Aragón, Instituto Aragonés de Ciencias de la Salud, Universidad de Zaragoza, Zaragoza, Spain
7CIBER de Enfermedades Cardiovasculares CIBERCV, Institute of Health Carlos III, Madrid, Spain
8Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra, Spain
9Cardiac Imaging Unit, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain
10CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain
∗
For correspondence: Vicenta Llorente-Cortes Vicenta.llorente@iibb.csic.escllorente@santpau.cat
Collection date 2026 Jan.
© 2025 The Authors
PMCID: PMC12768898 PMID: 41406782
This corrects the article "ApoB100 remodeling and stiffened cholesteryl ester core raise LDL aggregation in familial hypercholesterolemia patients" in volume 66, 100703.